UNSPSC 85501824: Bypass left subclavian artery to upper arm vein with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left subclavian artery to upper arm vein with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03140KD

UNSPSC 85501824 Bypass left subclavian artery to upper arm vein with nonautologous tissue substitute, open approach is a Commodity code that does not reflect the actual scope of recent state and local procurement activity tagged under it. The recent opportunities solicited under this code — independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, specialty emergency care for detained youth, pharmacy benefit management, and temporary health professional staffing — bear no relationship to the specific surgical procedure named in the code. State and local procurement offices appear to have applied this code incorrectly to health services and benefits management work rather than to implantable devices or surgical supplies. The mismatch signals either systematic miscoding or a data integrity issue in the source records; the code should not be used as a reliable signal of actual purchasing intent for the surgical procedure it nominally describes.

Recent activity shows health systems, counties, and municipalities posting RFPs and RFQs for occupational and disability medical evaluation services, employee health benefits administration, and clinical staffing pools rather than for the surgical implants or devices the code's name suggests. The City of Phoenix Retirement Office (RFP RTMRFP26001, due October 16, 2026) and the Washington State Department of Transportation on behalf of Washington State Ferries (RFP RFP20260825, due October 9, 2026) are among the issuing bodies. Unless procurement practice changes materially to align the code with the surgical procedure it describes, opportunities under this code are unlikely to support business development focused on vascular surgery devices or related implants.